UBS Investors Juggle Two Distinct Capital Questions as Bern's Compromise Takes Shape

Swiss committee softens UBS capital rules, but $13B AT1 need and CHF185M fund rights issue keep pressure on shares.

The market's verdict on UBS shares this week has been shaped by a legislative compromise that is both softer than feared and costlier than the bank would like — but the regulatory saga unfolding in Bern is only half the capital story investors are tracking.

A committee of Switzerland's upper house voted 10:2 on Monday to allow UBS's foreign subsidiaries to back just half of their capital requirements with core equity (CET1), with the remainder covered by restructured Additional Tier-1 (AT1) bonds. That departs from the Swiss Federal Council's original demand for 100 percent CET1 coverage, a position finance minister Karin Keller-Sutter defended on Tuesday, expressing disappointment that taxpayer protection was not sufficiently guaranteed under the committee's plan.

For shareholders, the practical impact is what matters. UBS calculates the committee's proposal would require roughly $13 billion in additional Tier-1 capital, plus another $2 billion in CET1 stemming from earlier regulatory changes. Since the Credit Suisse takeover, that brings the bank's cumulative additional capital burden to around $30 billion, offset by only about $4 billion in CET1 relief.

The share price reaction was telling: UBS fell 2.4 percent on Tuesday to close at €46.79, a reminder that investors are pricing the cost question seriously even though the proposal is milder than originally drafted.

A Second, Separate Capital Event

Meanwhile, a wholly distinct capital exercise is unfolding on the fund side. The management of a UBS real estate fund announced a rights issue of roughly CHF 185 million, slated for October or November 2026, with final terms expected at the end of September. Proceeds are earmarked for property acquisitions, renovation projects and reducing external financing.

For holders of units in the open-ended property fund, the move means potential dilution if they decline to take up their rights — a standard mechanism in the industry, but one that now carries concrete figures. The announcement is operationally separate from the group-level regulatory debate, yet it lands at a moment when UBS's capital structure is under heightened scrutiny from every angle.

The Bull Case: A Softer Landing Than Feared

Bank of America has maintained its buy recommendation on UBS despite the cost warning, pointing to the "more lenient" capital rules compared with the Federal Council's original proposal. The committee's approach would still require more capital than UBS holds today, but significantly less than the government initially sought — and crucially, in a structure weighted toward AT1 instruments, which are cheaper for the bank to issue than common equity.

CEO Sergio Ermotti had already pushed back against the "extreme" proposals from Bern, advocating for a more moderate path. If the committee's line holds through the legislative process, a major drag on return on equity would be removed, potentially allowing the stock to extend its recovery. The shares already trade more than 52 percent above their 52-week low of €30.87 and sit just 2.9 percent below their yearly high.

The Bear Case: The Debate Isn't Over

The counter-argument carries weight. Keller-Sutter has characterized the committee's decision as a solution "in the bank's favor," signaling that the Federal Council and parts of parliament may push for stricter requirements. Critics also note that UBS's leverage ratio of 4.5 percent trails comparable US banks, which run between 5 and 6 percent — a point that could regain traction in the National Council or in a potential referendum.

Should stricter CET1 requirements ultimately prevail, UBS would face higher capital costs than the $13 billion AT1 estimate implies. The bank's own concerns about competitive disadvantages against international rivals would also persist, and Tuesday's share price drop demonstrates how sensitively the market reacts to any escalation in the debate.

What to Watch Next

The immediate calendar offers two concrete milestones. The fund management will publish final terms for the capital increase at the end of September, and UBS reports third-quarter results on October 28. Between now and then, the stock is likely to oscillate between regulatory uncertainty and the bank's robust operational performance.

The second-quarter numbers, released roughly two weeks ago, remain a source of support: pre-tax profit of $3.9 billion, net income of $2.8 billion, and a 47 percent year-on-year increase in pre-tax profit across core business segments. Wealth management attracted $36 billion in net new assets during the quarter, bringing the first-half total to $73 billion, while assets under management climbed to $7.326 trillion from $6.881 trillion at the end of March.

Morgan Stanley raised its UBS price target from CHF 39 to CHF 40 in late July following the results, though that assessment predates the latest political developments.

For now, the stock sits 2.2 percent above its 50-day moving average of €45.77 — a modest gap suggesting the recent move is not overheated. The distance to the 52-week high of €48.19, reached on July 16, has widened to 2.7 percent, while the shares remain up 36 percent over twelve months and 18 percent year-to-date.

The legislative path ahead runs through the Council of States and then the National Council before any proposal becomes law. Until a final regulatory framework is settled, the capital question — in both its regulatory and fund-level forms — remains the central swing factor for UBS's valuation.